Growth Metrics

Palisade Bio (PALI) Return on Equity (2016 - 2025)

Palisade Bio has reported Return on Equity over the past 15 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Equity rose 2.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, up 2.0% year-over-year, with the annual reading at 0.0% for FY2025, 1.0% up from the prior year.
  • Return on Equity was 0.0% for Q4 2025 at Palisade Bio, up from 0.04% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.16% in Q3 2021 and troughed at 0.07% in Q4 2021.
  • The 5-year median for Return on Equity is 0.01% (2024), against an average of 0.01%.
  • Year-over-year, Return on Equity rose 15bps in 2021 and then decreased -17bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.07% in 2021, then soared by 82bps to 0.01% in 2022, then increased by 18bps to 0.01% in 2023, then plummeted by -105bps to 0.02% in 2024, then soared by 87bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for PALI's Return on Equity are 0.0% (Q4 2025), 0.04% (Q3 2025), and 0.03% (Q2 2025).